Wei Deng
Impact in
- Infectious Diseases top 1%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Viral gastroenteritis research and epidemiology
- Neurology top 5%
- Long-Term Effects of COVID-19
Papers in
-
- SARS-CoV-2 and COVID-19 Research 15
- COVID-19 Clinical Research Studies 13
- Viral gastroenteritis research and epidemiology 8
- Epidemiology 26
- Influenza Virus Research Studies 18
- Respiratory viral infections research 10
- Co-authors
- Chuan Qin (45 shared papers)Linlin Bao (31 shared papers)Pin Yü (20 shared papers)Fengdi Li (20 shared papers)Yanfeng Yao (13 shared papers)Hong Gao (6 shared papers)Hua Zhu (16 shared papers)Qi Lv (20 shared papers)
- Journals
- PLoS ONE (8 papers)Virology Journal (5 papers)Virology (2 papers)Medicine (2 papers)Virus Research (2 papers)
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Wei Deng
85 papers receiving 2.9k citations
Wei Deng's Hit Papers
Peers
Comparison fields: 5 of 138
- Infectious Diseases 1.1k
- Neurology 281
- Epidemiology 582
- Animal Science and Zoology 163
- Immunology 314
Countries citing papers authored by Wei Deng
This map shows the geographic impact of Wei Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Deng more than expected).
Fields of papers citing papers by Wei Deng
This network shows the impact of papers produced by Wei Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Deng. The network helps show where Wei Deng may publish in the future.
Co-authors
The 25 scholars most cited alongside Wei Deng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 91 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Treatment With Lopinavir/Ritonavir or Interferon-β1b Improves Outcome of MERS-CoV Infection in a Nonhuman Primate Model of Common Marmoset Hit paper breakdown → | 2015 | 483 |
| 2 | Mice transgenic for human angiotensin-converting enzyme 2 provide a model for SARS coronavirus infection. | 2007 | 185 |
| 3 | 2015 | 184 | |
| 4 | 2021 | 111 | |
| 5 | 2012 | 104 | |
| 6 | 2012 | 102 | |
| 7 | 2020 | 93 | |
| 8 | 2015 | 89 | |
| 9 | 2005 | 82 | |
| 10 | 2020 | 82 | |
| 11 | 2011 | 65 | |
| 12 | 2013 | 61 | |
| 13 | 2010 | 53 | |
| 14 | 2021 | 52 | |
| 15 | 2014 | 48 | |
| 16 | 2019 | 48 | |
| 17 | 2014 | 45 | |
| 18 | 2021 | 43 | |
| 19 | 2011 | 42 | |
| 20 | 2014 | 42 |
About Wei Deng
Wei Deng is a scholar working on Infectious Diseases, Epidemiology, Cardiology and Cardiovascular Medicine, Immunology and Molecular Biology, having authored 91 papers that have together received 2.9k indexed citations. Recurring topics across this work include Influenza Virus Research Studies (18 papers), SARS-CoV-2 and COVID-19 Research (15 papers), COVID-19 Clinical Research Studies (13 papers), Respiratory viral infections research (10 papers), Viral gastroenteritis research and epidemiology (8 papers), Viral Infections and Immunology Research (5 papers), Immune Response and Inflammation (4 papers) and Alzheimer's disease research and treatments (4 papers). The work is most often cited by research in Infectious Diseases (1.1k citations), Neurology (281 citations), Epidemiology (582 citations), Animal Science and Zoology (163 citations) and Immunology (314 citations). Wei Deng has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Chuan Qin, Linlin Bao, Pin Yü, Fengdi Li, Yanfeng Yao, Hong Gao, Hua Zhu, Qi Lv, Yanfeng Xu and Honglin Chen. Their work appears in journals such as PLoS ONE, Virology Journal, Virology, Medicine and Virus Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.